Amag Pharmaceuticals: “I know that it’s way too speculative, honestly. There are some really great drug stocks that are down so much, why not just go buy Lilly. “
Benefitfocus: “Well that’s a cloud-based company. I mean look, I’d rather see you in one of our [cloud] kings. ServiceNow would be in there, Workday, and of course Salesforce.com. “
Nio: “Well, you know it’s a total Chinese spec and I believe it’s gonna stay in business. It’s at three bucks. Never forget though: sometimes stocks can go down, even from $3.”
Hexo: “Here’s my thought: Don’t buy it. I like Canopy Growth, that’s the only one I’m really recommending right now, other than Cronos. “
CME Group: “CME is a winner and I feel like I should’ve gotten behind it when the stock was much lower. It’s never too late.”
Array Biopharma: “Man, that’s at a 52-week high. Why don’t you buy one at 52-week low. Why don’t you buy Bristol-Myers, because once that Celgene deal gets together, man, [CEO] Dr. [Giovanni] Caforio’s gonna do a great job.”
WATCH: Cramer’s lightning round
Disclosure: Cramer’s charitable trust owns shares of Salesforce.com and Microsoft.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer’s world? Hit him up!
– Jim Cramer Twitter – Facebook – Instagram
Questions, comments, suggestions for the “Mad Money” website? email@example.com